Stake sale lifts RACP cash pile
The investment company banked R327m from the Dis-Chem transaction – more than double the value accorded to its indirect stake in Dis-Chem
Investment company RECM & Calibre (RACP) finds itself flush with cash after notching up a large profit on selling an indirect holding in Dis-Chem ahead of the healthcare retailer’s listing on the JSE last week. According to interim results to end-September released on Monday, RACP banked net proceeds of R327m from the Dis-Chem transaction – more than double the R149m value accorded to the indirect stake in the retailer as at the end of the reporting period. The indirect stake in Dis-Chem was held through a 50% stake in Fledge Holdings. RACP CEO Piet Viljoen said the sale of the shares was part of an agreement that Fledge had with DisChem regarding the listing of the company on the JSE. As part of the process, Dis-Chem bought back its shares held in the Fledge structure in order to place these shares in the listing, Viljoen said. "We had no influence at Fledge … we were just a third party investor." Nevertheless, he said, RACP was delighted to exit the Fledge-Dis-Chem investment at a...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.